Want to join the conversation?
$AGN's products revenues jumped 112.8% to $3.51Bil. Botox revenue was $605MM for 3Q15 on continued strong performance in both aesthetic and therapeutic indications, and Restasis revenue was $328MM driven by continuing strong promotional efforts. Namenda XR revenue was $215MM as prescriptions and formulary coverage remained stable.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.
$FHN shares have dropped after its earnings missed analysts’ expectations. I’m worried whether the stock will slide further.